Advantages and challenges of LNP–mRNA delivery systems for engineered cell therapy (IMAGE)
Caption
Created with Figdraw. LNP-based mRNA delivery enables safe, transient, and controllable protein expression with rapid kinetics and scalable production. However, challenges include immunogenicity, manufacturing complexity, and limited clinical validation. Promising applications include CAR-T cell engineering and ligand-directed targeting within the tumor microenvironment (TME). CAR, chimeric antigen receptor; LNP, Lipid Nanoparticles; mRNA, messenger RNA.
Credit
Ying Liu
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted.
License
CC BY-NC